FTV.NYSEFortive CORP

10-K: Fortive Corporation 2023 Annual Report: Navigating Growth and Global Challenges

Sentiment:

Annual Results


Fortive Corporation's 2023 annual report highlights a year of revenue growth, strategic acquisitions, and ongoing efforts to manage global economic and operational challenges.

Capital raiseThe company entered into a term loan credit agreement for a $1.3 billion delayed-draw term loan facility.Fortive completed the sale of its registered offering of Euro-denominated senior unsecured notes due 2026 and 2029 for approximately $1.3 billion.

Summary

  • Fortive Corporation's 2023 annual report details a 4.1% increase in total sales, driven by a 4.8% growth in sales from existing businesses.
  • The company experienced a 0.6% reduction in sales due to the strengthening of the U.S. dollar.
  • The Intelligent Operating Solutions segment saw a 5.9% sales increase, while Precision Technologies grew by 4.6%, and Advanced Healthcare Solutions experienced a slight decrease of 0.1%.
  • Operating profit margins increased to 18.7% in 2023, up from 16.9% in 2022, due to price increases, productivity gains, and lower acquisition costs.
  • The company made four acquisitions in the Intelligent Operating Solutions segment for a total cash consideration of $101.4 million.
  • Fortive repurchased 4 million shares of its common stock at an average price of $68.20 per share.
  • The company expects full-year sales growth of approximately 6% to 8% in 2024, with growth from existing businesses projected at 2% to 4%.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with solid financial performance and strategic initiatives, but also acknowledges some challenges and risks. The company's growth and profitability are expected to continue, but there are some headwinds to monitor.

Positives

  • The company achieved a solid increase in sales from existing businesses, indicating strong organic growth.
  • Improved operating profit margins demonstrate effective cost management and pricing strategies.
  • Strategic acquisitions are expected to enhance the company's product portfolio and market position.
  • The share repurchase program and increased dividend reflect a commitment to returning value to shareholders.
  • The company's global operations provide diversification and stability.

Negatives

  • The strengthening of the U.S. dollar negatively impacted sales by 0.6%.
  • The Advanced Healthcare Solutions segment experienced a slight decrease in sales.
  • Restructuring activities resulted in charges of $58.6 million.
  • Cybersecurity incidents in the fourth quarter of 2023 caused operational disruptions.
  • The company faces ongoing challenges related to global logistics and supply chains.

Risks

  • Global economic conditions, including inflation and interest rate changes, could adversely affect the business.
  • Supply chain disruptions and reliance on sole or limited source suppliers pose risks to production.
  • Intense competition and pricing pressures could impact market share and profitability.
  • Failure to innovate and develop new products could lead to obsolescence.
  • Cybersecurity breaches and disruptions to information technology systems could harm operations.
  • International operations are subject to economic, political, and compliance risks.
  • Changes in tax laws and regulations could affect profitability.
  • The company has a significant amount of debt, which could impact financial flexibility.

Future Outlook

Fortive anticipates full-year sales growth of approximately 6% to 8% in 2024, with growth from existing businesses projected at 2% to 4%. The company expects foreign exchange rates to remain volatile and may adversely impact financial results.

Management Comments

  • Management believes that reporting the non-GAAP financial measure of sales from existing businesses provides useful information to investors by helping identify underlying growth trends in our business.
  • Management believes the exclusion of the effect of acquisitions and divestitures and currency translation may facilitate the assessment of underlying business trends and may assist in comparisons of long-term performance.
  • We will continue to deploy FBS to actively manage production challenges, collaborate with customers and suppliers to minimize disruptions and utilize pricing and other countermeasures to offset the aforementioned dynamics.

Industry Context

Fortive operates in a competitive environment with rapid technological changes and evolving industry standards. The company's focus on connected workflow solutions and strategic acquisitions aligns with broader industry trends towards digitalization and automation. The company's performance is also influenced by global economic conditions and geopolitical events.

Comparison to Industry Standards

  • Fortive's revenue growth of 4.1% is comparable to other industrial technology companies, but the company's focus on software and services provides a unique competitive advantage.
  • The company's operating profit margin of 18.7% is strong compared to industry averages, reflecting effective cost management and pricing strategies.
  • The company's strategic acquisitions are similar to those of other companies in the sector, but Fortive's disciplined approach to integration and focus on long-term value creation sets it apart.
  • Fortive's share repurchase program and increased dividend are in line with industry trends of returning value to shareholders.
  • The company's exposure to global markets is similar to other multinational corporations, but its geographic diversity helps mitigate risks associated with specific economies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation PolicyThe director compensation policy was amended and restated on June 6, 2023, outlining the annual retainers and equity awards for non-management directors.June 6, 2023The amended policy provides clarity on director compensation and aligns with best practices.

Legal Proceedings

  • The company is subject to various litigation and other legal and regulatory proceedings incidental to its business, but does not believe these will have a material effect on its financial position, results of operations or cash flows.

Related Party Transactions

  • The company had transactions with CommonSpirit Health, a related party due to a board member overlap, with sales of approximately $12.6 million and $10.6 million in 2023 and 2022, respectively.

Stakeholder Impact

  • Shareholders will benefit from the company's growth, share repurchases, and increased dividends.
  • Employees will benefit from the company's continued growth and development opportunities.
  • Customers will benefit from the company's innovative products and services.
  • Suppliers will benefit from the company's continued operations and growth.
  • Creditors will benefit from the company's strong financial position and ability to service its debt.

Next Steps

  • The company will continue to focus on organic growth, strategic acquisitions, and cost management.
  • Fortive will monitor global economic conditions and adjust its strategies as needed.
  • The company will continue to invest in research and development to drive innovation.
  • Fortive will work to mitigate supply chain disruptions and cybersecurity risks.

Key Dates

DateDescription
July 2, 2016Fortive separated from Danaher Corporation and became an independent, publicly-traded company.
September 30, 2022The company completed the sale of its Therapy Physics product line.
December 7, 2023Fortive entered into a term loan credit agreement for a $1.3 billion delayed-draw term loan facility.
December 14, 2023The company drew down $550 million of the $1.3 billion delayed-draw senior unsecured term facility.
January 3, 2024Fortive acquired EA Elektro-Automatik Holding GmbH.
February 13, 2024Fortive completed the sale of its registered offering of Euro-denominated senior unsecured notes due 2026 and 2029.

Keywords

Fortive, Intelligent Operating Solutions, Precision Technologies, Advanced Healthcare Solutions, financial results, acquisitions, sales growth, operating profit, share repurchase, dividends, cybersecurity, supply chain, global economy

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.